PRIA Logo™
TennesseeHB 1984114th General Assembly (2025-2026)House

AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.

Sponsored By: Sponsor information unavailable

Signed by Governor

Controlled Substances

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

On-site buprenorphine access with prescription limits

Tennessee law allows healthcare providers to directly give buprenorphine without naloxone on site to treat substance use disorder. Providers must act within their scope of practice. Treatment requires an order from a physician licensed under Title 63, Chapter 6 or 9, or a provider named in § 53-11-311(c)(2). This on-site option does not allow dispensing medicine for use elsewhere. Providers named in § 53-11-311(c)(2) generally cannot prescribe or dispense buprenorphine without naloxone. Exceptions cover pregnant or nursing patients, patients with a documented adverse reaction or hypersensitivity, and prescriptions for injectable buprenorphine-only products. The law took effect upon becoming law.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • John Crawford

    Republican • House

  • Rusty Grills

    Republican • House

  • Tim Hicks

    Republican • House

  • White

    Affiliation unavailable

Roll Call Votes

All Roll Calls

Yes: 136 • No: 4

House vote • 3/30/2026

FLOOR VOTE: CONSENT CALENDAR PASSAGE ON THIRD CONSIDERATION 3/30/2026

Yes: 82 • No: 1

Senate vote • 3/30/2026

FLOOR VOTE: Third Consideration 3/30/2026

Yes: 28 • No: 3

House vote • 3/26/2026

HOUSE CALENDAR & RULES COMMITTEE

Yes: 0 • No: 0

House vote • 3/17/2026

HOUSE HEALTH COMMITTEE

Yes: 20 • No: 0

House vote • 2/18/2026

HOUSE HEALTH SUBCOMMITTEE

Yes: 6 • No: 0

Actions Timeline

  1. Effective date(s) 04/16/2026

    4/24/2026

  2. Pub. Ch. 753

    4/24/2026

  3. Signed by Governor.

    4/16/2026

  4. Transmitted to Governor for his action.

    4/7/2026House

  5. Signed by Senate Speaker

    4/6/2026Senate

  6. Signed by H. Speaker

    4/6/2026House

  7. Enrolled; ready for sig. of H. Speaker.

    4/1/2026House

  8. Passed Senate, Ayes 28, Nays 3

    3/30/2026Senate

  9. Senate substituted House Bill for companion Senate Bill.

    3/30/2026Senate

  10. Received from House, Passed on First Consideration

    3/30/2026Senate

  11. Sponsor(s) Added.

    3/30/2026House

  12. Engrossed; ready for transmission to Sen.

    3/30/2026House

  13. Passed H., Ayes 82, Nays 1, PNV 10

    3/30/2026House

  14. H. Placed on Consent Calendar for 3/30/2026

    3/26/2026House

  15. Placed on cal. Calendar & Rules Committee for 3/26/2026

    3/25/2026House

  16. Rec. for pass; ref to Calendar & Rules Committee

    3/17/2026House

  17. Placed on cal. Health Committee for 3/17/2026

    3/11/2026House

  18. No Action Taken

    3/10/2026House

  19. Placed on cal. Health Committee for 3/10/2026

    3/4/2026House

  20. Action def. in Health Committee to 3/10/2026

    3/3/2026House

  21. Placed on cal. Health Committee for 3/3/2026

    2/25/2026House

  22. Sponsor(s) Added.

    2/25/2026House

  23. Rec. for pass by s/c ref. to Health Committee

    2/18/2026House

  24. Sponsor(s) Added.

    2/12/2026House

  25. Placed on s/c cal Health Subcommittee for 2/18/2026

    2/11/2026House

Bill Text

  • Enrolled / Public Chapter

    PDF

  • Fiscal Note

    PDF

  • Introduced

    PDF

Related Bills

Back to State Legislation